These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8892919)

  • 1. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
    J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
    Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
    J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.
    Vieillard V; Jouveshomme S; Leflour N; Jean-Pierre E; Debre P; De Maeyer E; Autran B
    J Virol; 1999 Dec; 73(12):10281-8. PubMed ID: 10559345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
    Kollmann TR; Pettoello-Mantovani M; Zhuang X; Kim A; Hachamovitch M; Smarnworawong P; Rubinstein A; Goldstein H
    J Exp Med; 1994 Feb; 179(2):513-22. PubMed ID: 8294863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
    Yoshida A; Tanaka R; Murakami T; Takahashi Y; Koyanagi Y; Nakamura M; Ito M; Yamamoto N; Tanaka Y
    J Virol; 2003 Aug; 77(16):8719-28. PubMed ID: 12885891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.
    Cao T; Leroux-Roels G
    Clin Exp Immunol; 2000 Oct; 122(1):117-23. PubMed ID: 11012627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
    Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
    Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus infection of xenografted SCID-beige mice.
    McBride BW; Easterbrook LM; Farrar GH
    J Med Virol; 1995 Oct; 47(2):130-8. PubMed ID: 8830116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.
    Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
    Clin Exp Immunol; 2020 May; 200(2):185-198. PubMed ID: 31951011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
    Di Fabio S; Giannini G; Lapenta C; Spada M; Binelli A; Germinario E; Sestili P; Belardelli F; Proietti E; Vella S
    AIDS; 2001 Nov; 15(17):2231-8. PubMed ID: 11698695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
    Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
    J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
    Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
    Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
    Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.